NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $223,000 | -14.2% | 2,100 | -51.7% | 0.01% | -8.3% |
Q4 2017 | $260,000 | -5.8% | 4,350 | -62.2% | 0.01% | 0.0% |
Q3 2017 | $276,000 | -43.6% | 11,500 | -54.0% | 0.01% | -42.9% |
Q2 2017 | $489,000 | -16.7% | 25,000 | 0.0% | 0.02% | -30.0% |
Q1 2017 | $587,000 | -52.2% | 25,000 | -75.0% | 0.03% | -48.3% |
Q4 2016 | $1,227,000 | – | 100,000 | – | 0.06% | – |
Q3 2013 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |